Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 65862-709

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 65862-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Raloxifene Fig1)

This document presents data on the percentage change in total hip bone mineral density (BMD) from baseline in subjects who received either placebo or raloxifene hydrochloride (a medication used to prevent osteoporosis) over a 24-month period. The results are shown in Figure 1, with separate data presented for studies conducted in North America and Europe and for hysterectomized women taking conjugated estrogens (CE). The data is analyzed using an "intent to treat" approach with last observation carried forward.*

FDA Label Image

Package Label-principal Display Panel (60 mg (30 Tablet Bottle))

This is a description of Raloxifene Hydrochloride, a prescription medication distributed by Aurobindo Pharma USA Inc. The tablets contain 60mg of Raloxifene hydrochloride USP and come packaged with a Medication Guide to be given to each patient. The recommended adult dosage is included in the package literature. The tablets should be stored in a tight container at controlled room temperature. If the inner seal is missing or broken, do not use. No non-English characters were detected.*

FDA Label Image

Package Label-principal Display Panel (60 mg Blister Carton (3 x 10 Unit-dose))

This is a package of Raloxifene Hydrochloride tablets containing 30 unit-dose tablets each. The tablets are USP approved, and each film-coated tablet contains Raloxifene hydrochloride. The tablets are stored at 20° to 25°C (68° to 77°F), and the package is not child-resistant. The medication guide is provided separately to each patient. The package also includes dosage instructions for adults and a warning not to print on the dotted lines.*

FDA Label Image

Chemical Structure (Raloxifene Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.